




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Prevention</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=f2cae575-0831-4309-9bdd-b6f6bc39064d</link>
        <description>Clinical Topic Feed: Prevention</description>
        <language>en</language>

        

                <item>
                    <title>A Rare Pattern of Harm: Statin-Associated Immune-Mediated Necrotizing Myopathy in Native American Populations</title>
<link>/Latest-in-Cardiology/Articles/2026/08/17/15/29/A-Rare-Pattern-of-Harm</link>                    <description>Statin therapy remains a cornerstone in the prevention of cardiovascular (CV) morbidity and mortality. Although statin-associated muscle symptoms are relatively common and often self-limited, severe statin-associated immune-mediated necrotizing myopathy (IMNM) has emerged as a rare but important clinical entity.</description>
                    <pubdate>1786989360000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>AI-Enabled Clinician: Best Practices of Wearables in Cardiovascular Care</title>
<link>/Latest-in-Cardiology/Articles/2026/08/12/20/15/ai-enabled-clinician-13aug2026</link>                    <description>In this episode, Drs. Ami Bhatt, Rupal O&#226;€™Quinn, and Leon Ptaszek delve into the role of consumer wearables in cardiovascular care.</description>
                    <pubdate>1786636800000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#39;s Eye View: Lifestyle Intervention Benefits Health Status in ANOCA Patients</title>
<link>/Latest-in-Cardiology/Articles/2026/08/10/13/07/eagles-eye-view-12aug2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle looks at the wide variation in antithrombotic regimens after valve-in-valve transcatheter aortic valve replacement (TAVR). Next, he examines PARTNER-3, a 7-year study on TAVR versus surgical aortic valve replacement (SAVR) outcomes in low-risk patients.</description>
                    <pubdate>1786537680000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACCEL Lite: Evolocumab In Patients Without Significant Atherosclerosis: Results From VESALIUS-CV</title>
<link>/Latest-in-Cardiology/Articles/2026/08/10/13/07/accel-lite-11aug2026</link>                    <description>In this interview, Nanette Kass Wenger MD, MACC and Nicholas Marston, MD discuss the VESALIUS-CV Trial.</description>
                    <pubdate>1786460400000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACC Scientific Statement Addresses Cognitive Impairment, Frailty in Patients With CV Disease</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/08/10/15/19/ACC-Scientific-Statement-Addresses-Cognitive-Impairment-Frailty</link>                    <description>With older adults rarely experiencing cardiovascular disease in isolation, ACC&#39;s newest Scientific Statement on &quot;Cognitive Impairment and Frailty in Older Adults With Cardiovascular Disease&quot; stresses the importance of considering cognitive impairment, frailty and physical disability within the context of cardiovascular decision-making.</description>
                    <pubdate>1786376640000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACC CardiaCast: Risk Assessment and Genetics in the Prevention of Cardiovascular Disease </title>
<link>/Latest-in-Cardiology/Articles/2026/08/10/13/07/cardiacast_10aug2026</link>                    <description>This episode of CardiaCast will feature a discussion on risk assessment and genetics in the prevention of cardiovascular disease.</description>
                    <pubdate>1786367400000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACC CardiaCast: Risk Assessment and Treatment of Hypertriglyceridemia</title>
<link>/Latest-in-Cardiology/Articles/2026/08/04/15/47/cardiacast_07aug2026</link>                    <description>This episode of CardiaCast will feature a discussion on risk assessment and the treatment of hypertriglyceridemia.</description>
                    <pubdate>1786111200000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>GBD Study 2023: LDL-C Burden Increasing Globally</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/08/05/20/14/GBD-Study-2023</link>                    <description>The global burden attributable to elevated LDL-C has grown substantially since 1990, driven largely by population growth and aging despite significant declines in age-standardized rates, according to findings from the Global Burden of Disease Study 2023 (GBD 2023) Cholesterol Collaborators published July 29 in JAMA.</description>
                    <pubdate>1786042800000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>SAMCRO: Lifestyle Intervention Improves Angina-Related Health Status in ANOCA</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/08/05/20/14/SAMCRO</link>                    <description>In patients with invasively confirmed angina with no obstructive coronary artery disease (ANOCA), adding a structured multidomain lifestyle intervention to medical therapy tailored to each patient&#226;€™s ANOCA endotype led to clinically meaningful improvements in patient-reported health status, according to results from the prospective SAMCRO trial published July 27 in JACC: Cardiovascular Interventions.</description>
                    <pubdate>1785963540000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>New ACC Concise Clinical Guidance Focuses on Adult Immunizations as Part of CV Care</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/08/03/10/06/New-ACC-Concise-Clinical-Guidance-Focuses-on-Adult-Immunizations</link>                    <description>The ACC has released an updated Concise Clinical Guidance document addressing &quot;Adult Immunizations as Part of Cardiovascular Care,&quot; providing clinicians with vaccine-specific guidance related to the influenza, pneumococcal, COVID-19, RSV and zoster (shingles) vaccines, respectively.</description>
                    <pubdate>1785947040000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>